On December 15, 2022, James T. LaFrance resigned from the board of directors of Aspira Women's Health Inc., effective immediately. Following Mr. LaFrance's resignation, the Board appointed Dr. Robert Auerbach to the Audit Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 USD | -8.74% |
|
-28.24% | -76.96% |
Jul. 02 | Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech | MT |
Jul. 01 | Aspira Women's Health Inc.(NasdaqCM:AWH) added to Russell 3000E Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.96% | 11.7M | |
-41.62% | 7.97B | |
-9.10% | 2.07B | |
-29.56% | 1.77B | |
-21.96% | 1.64B | |
+6.72% | 928M | |
+24.08% | 777M | |
-9.17% | 696M | |
-30.82% | 500M | |
-16.50% | 245M |
- Stock Market
- Equities
- AWH Stock
- News Aspira Women's Health Inc.
- Aspira Women's Health Inc. Announces Executive Changes